IT1246983B - L-2'-desossiuridine e composizioni farmaceutiche che le contengono. - Google Patents

L-2'-desossiuridine e composizioni farmaceutiche che le contengono.

Info

Publication number
IT1246983B
IT1246983B IT02203290A IT2203290A IT1246983B IT 1246983 B IT1246983 B IT 1246983B IT 02203290 A IT02203290 A IT 02203290A IT 2203290 A IT2203290 A IT 2203290A IT 1246983 B IT1246983 B IT 1246983B
Authority
IT
Italy
Prior art keywords
desoxyuridine
contain
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IT02203290A
Other languages
English (en)
Other versions
IT9022032A0 (it
IT9022032A1 (it
Inventor
Stefano Iotti
Francesco Paolo Colonna
Anna Maria Garbesi
Silvio Spadari
Federico Focher
Giovanni Ciarrocchi
Federico Arcamone
Original Assignee
Consiglio Nazionale Ricerche
Menarini Ricerche Sud Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche, Menarini Ricerche Sud Spa filed Critical Consiglio Nazionale Ricerche
Priority to IT02203290A priority Critical patent/IT1246983B/it
Publication of IT9022032A0 publication Critical patent/IT9022032A0/it
Priority to AU89232/91A priority patent/AU8923291A/en
Priority to PCT/EP1991/002134 priority patent/WO1992008727A1/en
Publication of IT9022032A1 publication Critical patent/IT9022032A1/it
Application granted granted Critical
Publication of IT1246983B publication Critical patent/IT1246983B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT02203290A 1990-11-13 1990-11-13 L-2'-desossiuridine e composizioni farmaceutiche che le contengono. IT1246983B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT02203290A IT1246983B (it) 1990-11-13 1990-11-13 L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
AU89232/91A AU8923291A (en) 1990-11-13 1991-11-09 L-2'-desoxyuridines and pharmaceutical compositions containing them
PCT/EP1991/002134 WO1992008727A1 (en) 1990-11-13 1991-11-09 L-2'-desoxyuridines and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02203290A IT1246983B (it) 1990-11-13 1990-11-13 L-2'-desossiuridine e composizioni farmaceutiche che le contengono.

Publications (3)

Publication Number Publication Date
IT9022032A0 IT9022032A0 (it) 1990-11-13
IT9022032A1 IT9022032A1 (it) 1992-05-13
IT1246983B true IT1246983B (it) 1994-12-12

Family

ID=11190463

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02203290A IT1246983B (it) 1990-11-13 1990-11-13 L-2'-desossiuridine e composizioni farmaceutiche che le contengono.

Country Status (3)

Country Link
AU (1) AU8923291A (it)
IT (1) IT1246983B (it)
WO (1) WO1992008727A1 (it)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642245B1 (en) 1990-02-01 2003-11-04 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
US5827727A (en) * 1990-02-01 1998-10-27 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9218810D0 (en) * 1992-09-04 1992-10-21 Univ Birmingham Antiviral pyrimidine nucleosides
FR2709754B1 (fr) * 1993-09-10 1995-12-01 Centre Nat Rech Scient Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale.
US20020120130A1 (en) 1993-09-10 2002-08-29 Gilles Gosselin 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
MX9702927A (es) * 1994-10-24 1998-04-30 Genencor Int L-piranosilnucleosidos.
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
US5753789A (en) * 1996-07-26 1998-05-19 Yale University Oligonucleotides containing L-nucleosides
AU738170B2 (en) * 1996-10-16 2001-09-13 Icn Pharmaceuticals, Inc. Monocyclic L-nucleosides, analogs and uses thereof
EP1302474A1 (en) * 1996-10-16 2003-04-16 Ribapharm, Inc. Monocyclic L-nucleosides, analogs and uses thereof
EA200700564A1 (ru) 1998-02-25 2007-08-31 Эмори Юниверсити 2`-фторнуклеозиды
US6444652B1 (en) 1998-08-10 2002-09-03 Novirio Pharmaceuticals Limited β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
EP1431304B1 (en) * 1998-08-10 2014-12-03 Novartis AG Beta - L-2'-Deoxy-Nucleosides for the treatment of Hepatitis B
DE69929060T2 (de) * 1998-08-10 2006-08-31 Idenix (Cayman) Ltd. Beta-l-2'-deoxynukleoside für die behandlung von hepatitis b virus
AU2007216721B2 (en) * 1998-08-10 2011-05-19 Centre National De La Recherche Scientifique Beta-L-2'-Deoxy Nucleosides for the Treatment of Hepatitis B
AU2011211428B2 (en) * 1998-08-10 2013-02-07 Centre National De La Recherche Scientifique Beta-L-2'-Deoxy Nucleosides for the treatment of Hepatitis B
CN101120947B (zh) * 1998-08-10 2010-11-24 艾丹尼克斯(开曼)有限公司 用于治疗乙型肝炎的β-L-2′-脱氧-核苷
BR0015530A (pt) * 1999-11-12 2003-02-18 Pharmasset Ltd Sìntese de 2'-desoxi-l-nucleosìdeo
EP1634888A3 (en) * 1999-11-12 2007-11-21 Pharmasset, Inc. Synthesis of 2'-deoxy-L-nucleosides
US6787526B1 (en) 2000-05-26 2004-09-07 Idenix Pharmaceuticals, Inc. Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
MY141594A (en) * 2000-06-15 2010-05-14 Novirio Pharmaceuticals Ltd 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
US6875751B2 (en) 2000-06-15 2005-04-05 Idenix Pharmaceuticals, Inc. 3′-prodrugs of 2′-deoxy-β-L-nucleosides
CA2426187C (en) 2000-10-18 2011-08-16 Pharmasset Limited Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
BR0210594A (pt) 2001-06-22 2005-11-01 Pharmasset Ltd (beta)-d ou (beta)-l-3-halonucleosìdeo
TWI244393B (en) 2002-08-06 2005-12-01 Idenix Pharmaceuticals Inc Crystalline and amorphous forms of beta-L-2'-deoxythymidine
AU2003278816A1 (en) 2002-09-13 2004-04-30 Idenix (Cayman) Limited ss-L-2'-DEOXYNUCLEOSIDES FOR THE TREATMENT OF RESISTANT HBV STRAINS AND COMBINATION THERAPIES
US8895531B2 (en) 2006-03-23 2014-11-25 Rfs Pharma Llc 2′-fluoronucleoside phosphonates as antiviral agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0217580A3 (en) * 1985-09-17 1990-11-07 The Wellcome Foundation Limited Therapeutic nucleosides
DD279407A1 (de) * 1986-07-24 1990-06-06 Akad Wissenschaften Ddr Verfahren zur herstellung eines mittels gegen aids
FR2640267B2 (fr) * 1988-01-19 1992-02-14 Univ Paris Curie Procede de synthese de l'azido-3(prime)-desoxy-3(prime)-thymidine et analogues
FR2627492B1 (fr) * 1988-02-24 1990-08-10 Irceba Nouveaux derives de l'amino-5(prime)-dideoxy-2(prime)-5(prime)-uridine, procede pour les preparer et compositions pharmaceutiques contenant ces composes
SE8802687D0 (sv) * 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives

Also Published As

Publication number Publication date
IT9022032A0 (it) 1990-11-13
AU8923291A (en) 1992-06-11
WO1992008727A1 (en) 1992-05-29
IT9022032A1 (it) 1992-05-13

Similar Documents

Publication Publication Date Title
IT1246983B (it) L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
MX9102473A (es) Agentes farmaceuticos.
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
BR9205818A (pt) Composições azeotrópicas de 1,1,2,2-tetrafluororetano e semelhantes.
FI912443L (fi) Polydextroskompositioner.
FI925661L (fi) Injicerbar farmaceutisk komposition
EP0599532A3 (en) One-component curable organosiloxane compositions.
FI911738A7 (fi) Anordning foer administrering av pulverformiga medicinska aemnen.
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
BR9101573A (pt) Composicao de xampu
BR9200058A (pt) Composto e composicao farmaceutica
FI931225L (fi) Milda shampokompositioner
MX9204547A (es) Neristatina 1.
FI910088L (fi) Oral farmaceutisk komposition.
IS1605B (is) Botnv”rpuutbunathur
FI923449L (fi) Kosmetiska kompositioner.
UA26064A1 (uk) Фармацевтичhа композиція
DE59003130D1 (de) Mikrobizid-Formulierungen und deren Verwendung.
FI913639A7 (fi) Farmaceutiska kompositioner.
FI923371A0 (fi) En farmaceutisk formulation.
FR2664162B1 (fr) Composition cosmetique.
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
FI920158A7 (fi) Foerfarande foer framstaellning av 3'-fluorpyrimidinnukleosider.
EP0643669A4 (en) Zinc phosphorous oxide and zinc arsenic oxide compositions.
FI921756A0 (fi) Foerfarande foer framstaellning av 4'-demetyliepipodofyllotoxin glukosid 4'-fosfater.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971128